InvestorsHub Logo
Followers 166
Posts 36223
Boards Moderated 7
Alias Born 10/20/2019

Re: None

Friday, 09/23/2022 6:48:56 AM

Friday, September 23, 2022 6:48:56 AM

Post# of 155
$MYNZ - Achieved multiple preclinical milestones supporting the continued development of PancAlert, a potential first-in-class screening test for pancreatic cancer.
https://finance.yahoo.com/news/mainz-biomed-reports-first-half-070100420.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYNZ News